Načítá se...
Is microfluidics the “assembly line” for CRISPR-Cas9 gene-editing?
Acclaimed as one of the biggest scientific breakthroughs, the technology of CRISPR has brought significant improvement in the biotechnological spectrum—from editing genetic defects in diseases for gene therapy to modifying organisms for the production of biofuels. Since its inception, the CRISPR-Cas...
Uloženo v:
| Vydáno v: | Biomicrofluidics |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
AIP Publishing LLC
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7688342/ https://ncbi.nlm.nih.gov/pubmed/33262863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1063/5.0029846 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|